Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 10, 2003Annals of Pharmacotherapy

Infliximab Treatment of Rheumatoid Arthritis and Crohn's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

INIbrahim NaharKSKam ShojaniaSt. Paul's HospitalCMCarlo A. MarraPolytechnic University of Turin

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nahar et al. (2003) studied this question.

synapsesocial.com/papers/6a98dae5174d19d294aef8bfhttps://doi.org/10.1345/aph.1c039
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease1997 · 3,169 citations
  2. 2Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease1999 · 2,766 citations
  3. 3Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis1999 · 436 citations
  4. 4Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis1998 · 1,642 citations